We are live on
!
Find out more
NERM
New England Research & Management Portfolio holdings
AUM
$257M
1-Year Est. Return
25.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$170M
AUM Growth
-$3.54M
(-2%)
Cap. Flow
-$1.18M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
23.13%
Holding
180
New
28
Increased
33
Reduced
64
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$2.22M |
| 2 |
LyondellBasell Industries
LYB
|
+$1.49M |
| 3 |
Chubb
CB
|
+$1.46M |
| 4 |
Dollar Tree
DLTR
|
+$1.45M |
| 5 |
Amgen
AMGN
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prosperity Bancshares
PB
|
+$2.95M |
| 2 |
ON Semiconductor
ON
|
+$1.24M |
| 3 |
Merck
MRK
|
+$1.23M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$1.22M |
| 5 |
American Express
AXP
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.11% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Staples | 14.05% |
| 4 | Financials | 9.51% |
| 5 | Technology | 9.2% |
Similar funds
GCCM
EBWM
HFRG
ACM
CCA
PHAM
TC
New England Research & Management's Q1 2023 Portfolio in Review
As of Q1 2023, New England Research & Management held 180 positions worth $170M, down 2% from $174M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
New England Research & Management's Q1 2023 filing shows 28 new, 33 increased, 64 reduced and 37 closed positions. Its largest new stake was Charles Schwab: 30,305 shares worth $1.59M. The largest sale was Prosperity Bancshares, an estimated $2.95M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.
- New England Research & Management's largest Q1 2023 buy was Charles Schwab: 30,305 shares worth $1.59M.
- New England Research & Management added most to Amgen in Q1 2023, an estimated $1.17M increase.
- New England Research & Management's biggest Q1 2023 reduction was Merck, cutting an estimated $1.23M.
- New England Research & Management fully exited Prosperity Bancshares in Q1 2023, selling an estimated $2.95M.
- New England Research & Management's ten largest holdings make up 23% of its $170M portfolio in Q1 2023.
- New England Research & Management opened 28 new positions and closed 37 in Q1 2023.
- New England Research & Management's portfolio value fell 2% quarter-over-quarter to $170M.
Based on New England Research & Management's 13F filing for Q1 2023, filed 6 Apr 2023.